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The Toronto Critical Care Medicine Symposium took place
on 18–20 October 2001. Despite worldwide concerns with
air travel, international faculty and participants turned out in
large numbers. There were many exciting mini-symposia on
topics ranging from nutritional support, sedation, and neuro-
critical care to medical errors and end-of-life care. Focused
learning sessions on controversial critical care topics pro-
vided practical guidance to clinicians. There were also work-
shops on hand-held technology and patient simulators. This
meeting report presents highlights from the symposium.
Sepsis
In his provocative presentation, Dr Gordon Rubenfeld asked
whether sepsis was a disease. When there is no gold stan-
dard for diagnosis, he suggested that lessons could be
learned from rheumatology and psychiatry in creating reliable
and valid diagnostic criteria for sepsis. Dr John Marshall
expanded on this theme in his novel presentation on the inter-
face between oncology and sepsis. He emphasized the need
for clearly defining homogenous patient populations for testing
sepsis therapies. He proposed an IRO (Insult, Response,
Organ dysfunction) staging system that might be helpful in this
regard, just as TNM (Tumor, Nodes, Metastasis) staging is in
oncology trials. Dr James Russell addressed issues arising
from the PROWESS trial [1] of activated protein C (APC). He
explained how sepsis results in inflammation and abnormalities
of coagulation, anti-coagulation and fibrinolysis. Further
research into the genetic profile that decreases APC activity
might highlight those patients who could potentially benefit
most from this novel therapy. Similarly, Dr Phillip Dellinger
emphasized that although anti-tumor-necrosis-factor therapy
has not shown a statistically significant benefit in trials and
meta-analysis, the signal of benefit might be increased by
careful patient selection. Finally, in looking at old therapies cur-
rently being revisited, Dr Mitch Levy reviewed some new data
from Dr Djillali Annane’s latest study of low-dose steroids in
sepsis (unpublished data) that demonstrate a statistically sig-
nificant reduction in 28-day all-cause mortality.
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Abstract
At the 2001 Toronto Critical Care Medicine Symposium, exciting new research results were
presented, including a randomized trial of peri-operative pulmonary-artery catheter use and evidence-
based guidelines for the prevention of ventilator-acquired pneumonia. Presenters reviewed other
important recent critical care developments such as (1) activated protein C and low-dose steroids in
sepsis, (2) prone positioning and long-term outcomes in patients with adult respiratory distress
syndrome, and (3) medical errors in the critical care unit. Along with these new findings, another theme
emerged during the symposium. This theme emphasized that research breakthroughs are not sufficient
in themselves: outcome studies are needed to learn how new research is applied on a large-scale
basis within actual clinical practice. Furthermore, additional study is needed for an understanding of
how physicians implement new research findings. Successful methods of enhancing the widespread
adoption of new research require further study.
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Adult respiratory distress syndrome (ARDS)
Dr Luciano Gattinoni presented results from his recent publi-
cation [2] on prone positioning in the ventilation of ARDS
patients. Possibly owing to under-powering of the trial, prone
positioning did not show an overall mortality benefit despite
improving patient oxygenation. However, post-hoc analysis
demonstrated a significant benefit in the quartile of patients
with the most severe oxygenation difficulties. The trial also
demonstrated a very low rate of complications from prone
positioning. Thus, further investigation may be warranted
among patients with the most severe ARDS.
Dr Margaret Herridge presented the latest results from her
long-term follow-up of ARDS survivors. During 2 years of
follow-up, patients continue to show improvement toward
their baseline pre-ARDS health status. Patients have signifi-
cant generalized muscle weakness and fatigue that limits
their activities of daily living and 6-minute walk distance.
Despite this, 42% and 64% of patients have returned to their
original work by 1 and 2 years, respectively. Interesting
results will continue to be generated during the continuing
5-year follow-up of this cohort.
Pulmonary artery catheters in high-risk 
peri-operative patients
Dr Dean Sandham presented results of his recent multi-centre
trial (unpublished data) of peri-operative use of pulmonary
artery catheters (PACs). In his trial, 1994 patients more than
60 years old requiring surgery were randomized to the use or
non-use of PACs in optimizing their peri-operative hemody-
namic status. Patient mortality at 28 days and 1 year were not
significantly different between groups. He cautioned that there
was a significantly higher rate of pulmonary embolus and
catheter-related complications in the PAC group that, over a
large group of patients, would cause significant morbidity.
Strategies to reduce ventilator-associated
pneumonia (VAP)
On behalf of the Canadian Critical Care Task Force, Dr Peter
Dodek presented new clinical practice guidelines for VAP
(unpublished data). These guidelines were developed under a
rigorous methodology not used in previous VAP guideline
development. Recommendations include the use of orotra-
cheal (rather than nasotracheal) intubation, non-invasive posi-
tive-pressure ventilation (where possible), and 45° patient
positioning. Ventilator circuits and closed endotracheal tube
suctioning should be changed only with a new patient or
soiling. Finally, sucralfate and topical gastrointestinal decon-
tamination are not recommended in preventing VAP.
Integration of new research into practice
Dr William Sibbald gave an interesting plenary address on
adopting new research into clinical practice. Using sepsis
research as an example, he commented that the most rigor-
ous methods must be used in bench research before starting
clinical trials, to maximize success at the bedside. However,
despite good trials, clinicians might fail to practise the most
effective form of care. ARDSnet investigator Dr Taylor
Thompson illustrated this in another presentation, by com-
menting that even ARDS trial centres might not be using
6 cc/kg ideal body weight in ventilating patients. Dr Sibbald
postulated that more aggressive marketing of research suc-
cesses jointly with industry, within lay media, and with govern-
ment might improve clinical application. In describing new
ARDS trials under way, Dr Maureen Meade agreed with Dr
Thompson that ground-breaking qualitative research into bar-
riers to the implementation of new research is also necessary.
Reducing medical errors in the intensive care
unit
As one of the most provocative sessions of the symposium,
Dr Beverley Orser introduced the scope of medical errors by
describing the high human and medical cost of errors. Dr Ed
Etchells discussed the problem of disclosure of medical
error. Dr Kim Vincent described a comparative evaluation of
two human–computer interfaces for a commercially available
patient-controlled analgesia machine. This comparison
demonstrated how insufficient attention to appropriate design
of the human–computer interface contributes to medication
errors. Finally, Mr Ron Kaczorowski highlighted how the criti-
cal care environment is conducive to medical errors because
of the multitude of processes required in the acquisition of
patient data, and the lack of technological integration of data
transfer and communication to physicians and staff.
Conclusion: a research agenda
One theme permeated the symposium presentations: research
breakthroughs are not in themselves sufficient to improve
patient care. Large-scale studies of patient outcomes in the
real world are necessary to address how successfully research
is being integrated into clinical practice. Novel qualitative
research into changes in physician behavior is required to inte-
grate new research successfully into critical care practice so as
to maximize patient survival and quality of life. This is our chal-
lenge as intensivists charged with the care of critically ill
patients. We look forward to progress with these challenges at
next year’s Symposium, on 31 October to 2 November 2002.
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